Do bupropion (Wellbutrin) and clopidogrel (Plavix) together increase bleeding risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wellbutrin (Bupropion) Does NOT Increase Bleeding Risk When Combined with Plavix (Clopidogrel)

Bupropion (Wellbutrin) is not associated with increased bleeding risk when taken with clopidogrel (Plavix). The bleeding risk you need to worry about comes from Plavix itself, not from any interaction with Wellbutrin.

Understanding the Real Bleeding Risk

Plavix alone increases bleeding risk because it is an antiplatelet agent that inhibits platelet aggregation for the lifetime of the platelet (7-10 days) 1. This is the medication's intended mechanism of action, not a drug interaction issue.

Baseline Bleeding Rates with Plavix:

  • Clopidogrel alone: Associated with GI bleeding risk, though lower than aspirin (2.0% vs 2.7%) 2
  • Dual antiplatelet therapy (Plavix + aspirin): Increases bleeding 2- to 3-fold compared to aspirin alone, with absolute risk increases of 0.6-2.0% 2
  • Major bleeding rates: 2.7-3.7% in acute coronary syndrome trials 2, 3

The Wellbutrin-Plavix Interaction: Metabolic, Not Bleeding-Related

The documented interaction between these medications involves drug metabolism through CYP2B6, not bleeding risk 4. Specifically:

  • Clopidogrel inhibits CYP2B6, the enzyme that metabolizes bupropion
  • This reduces bupropion's conversion to hydroxybupropion by 52% 4
  • The result: increased bupropion levels (60% higher AUC) 4

Clinical Implications of This Metabolic Interaction:

  • You may need to adjust bupropion dosing downward if side effects emerge (anxiety, insomnia, tremor, seizure risk at high levels)
  • This is about bupropion toxicity risk, not bleeding
  • Monitor for bupropion-related adverse effects, particularly neuropsychiatric symptoms

What Actually Increases Bleeding Risk with Plavix

Focus your attention on these definite risk factors 2, 1:

High-Risk Factors:

  • Prior GI bleeding history (strongest predictor) 2
  • Concomitant aspirin use: Increases major bleeding OR 2.83 (95% CI 2.04-3.94) 5
  • Anticoagulants (warfarin, DOACs): Substantially increases bleeding 6, 1
  • NSAIDs and chronic NSAID use 2, 1
  • Corticosteroids 2

Moderate-Risk Factors:

  • Advanced age 2
  • Duration of therapy >6 months (OR 1.74,95% CI 1.21-2.50) 5
  • Helicobacter pylori infection 2

Medications That Affect Bleeding Through CYP2C19:

  • SSRIs/SNRIs: Listed as bleeding risk factors 1
  • Strong CYP2C19 inducers: May potentiate bleeding by increasing active metabolite levels 1

Common Pitfall to Avoid

Do not confuse metabolic drug interactions with bleeding risk. The fact that clopidogrel affects bupropion metabolism does not translate to increased bleeding. High-throughput pharmacoepidemiologic screening of clopidogrel interactions identified 28 drug pairs associated with serious bleeding 7, and bupropion was not among them.

Practical Management

Continue both medications without concern for bleeding interaction, but:

  1. Monitor for bupropion side effects (the actual interaction concern)

  2. Assess true bleeding risk factors using the list above

  3. Consider PPI prophylaxis if patient has:

    • History of upper GI bleeding 2
    • Multiple bleeding risk factors 2
    • Dual antiplatelet therapy 2
  4. Do NOT routinely use PPIs in low-risk patients 2

The 2010 ACCF/ACG/AHA consensus explicitly states that bleeding risk management should focus on established risk factors like anticoagulants, NSAIDs, and prior bleeding history 2—not on medications like bupropion that lack antiplatelet or anticoagulant properties.

Related Questions

What are the risks and precautions for a patient with cardiovascular disease taking clopidogrel and apixaban (Elequis) who engages in weight lifting?
What are the concerns for a patient taking Clopidogrel and Apixaban who also consumes green tea, particularly regarding the risk of bleeding?
Can clopidogrel (Plavix) and escitalopram (Lexapro) increase the risk of bruising?
What are the side effects of clopidogrel and the benefits of turmeric, and how might turmeric affect bleeding risk when taken with clopidogrel?
Can clopidogrel (Plavix) be taken with meloxicam, and what are the bleeding risks?
What medications should be prescribed for a presumed viral upper respiratory infection?
What are the recommended non‑invasive ventilation (NIV) settings for an adult with acute respiratory distress syndrome (ARDS)?
In a patient with persistent nasal congestion due to a presumed viral upper‑respiratory infection, how should intranasal corticosteroids be used (dosing, duration, tapering), what are the contraindications, and what alternatives are recommended if they cannot be used?
Can you provide quantitative facts (numbers or percentages) demonstrating why the golden hour is important in emergency medicine beyond trauma, and list actions that minimize time loss to improve survival?
What is the recommended fluticasone nasal spray dosage, daily frequency, and treatment duration for an adult with a viral upper‑respiratory infection, and how should the dose be adjusted for children aged 2–4 years?
Is it safe to initiate phenytoin in a patient with severe hyponatraemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.